[go: up one dir, main page]

ATE415166T1 - Antivirale pharmazeutische zusammensetzungen - Google Patents

Antivirale pharmazeutische zusammensetzungen

Info

Publication number
ATE415166T1
ATE415166T1 AT04821304T AT04821304T ATE415166T1 AT E415166 T1 ATE415166 T1 AT E415166T1 AT 04821304 T AT04821304 T AT 04821304T AT 04821304 T AT04821304 T AT 04821304T AT E415166 T1 ATE415166 T1 AT E415166T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
antiviral pharmaceutical
present
antiviral
antiviral compositions
Prior art date
Application number
AT04821304T
Other languages
English (en)
Inventor
Andrew Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE415166T1 publication Critical patent/ATE415166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04821304T 2003-12-10 2004-12-08 Antivirale pharmazeutische zusammensetzungen ATE415166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52884303P 2003-12-10 2003-12-10
US11/003,302 US7968122B2 (en) 2003-12-10 2004-12-03 Anti-viral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE415166T1 true ATE415166T1 (de) 2008-12-15

Family

ID=34840339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04821304T ATE415166T1 (de) 2003-12-10 2004-12-08 Antivirale pharmazeutische zusammensetzungen

Country Status (16)

Country Link
US (2) US7968122B2 (de)
EP (1) EP1706122B1 (de)
JP (1) JP2007513959A (de)
KR (1) KR20060118573A (de)
AT (1) ATE415166T1 (de)
AU (1) AU2004315262A1 (de)
BR (1) BRPI0417559A (de)
CA (1) CA2549083A1 (de)
DE (1) DE602004018032D1 (de)
DK (1) DK1706122T3 (de)
EA (1) EA200601124A1 (de)
IL (1) IL176161A0 (de)
MA (1) MA28334A1 (de)
MX (1) MXPA06006650A (de)
NO (1) NO20063147L (de)
WO (1) WO2005074947A2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007006860A (es) * 2004-12-09 2008-02-15 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
US20080199535A1 (en) * 2004-12-09 2008-08-21 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
CA2588802A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
AU2005314298A1 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
WO2007024973A1 (en) * 2005-08-22 2007-03-01 Quick-Med Technologies, Inc. Disinfectant with quaternary ammonium polymers and copolymers
US20080000473A1 (en) * 2005-12-29 2008-01-03 Hugo Stephenson pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion
EP2040716B1 (de) * 2006-04-04 2010-07-28 Marinomed Biotechnologie GmbH Cellulosesulfat zur behandlung von rhinovirus-infektionen
EP1842546B1 (de) * 2006-04-04 2009-03-11 Marinomed Biotechnologie GmbH Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen
US20090238883A1 (en) * 2006-04-28 2009-09-24 Kren Betsy T Liver-specific nanocapsules and methods of using
US20070274926A1 (en) * 2006-05-26 2007-11-29 The Dial Corporation Method of inhibiting the transmission of viruses
RU2008152402A (ru) * 2006-05-30 2010-07-10 Дзе Дайл Корпорейшн (Us) Композиции, обладающие сильным противовирусным действием
WO2007142967A2 (en) * 2006-05-31 2007-12-13 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
US8337872B2 (en) 2006-06-02 2012-12-25 The Dial Corporation Method of inhibiting the transmission of influenza virus
EP2046120A2 (de) * 2006-06-05 2009-04-15 The Dial Corporation Verfahren und artikel mit hoher antiviraler und antibakterieller wirksamkeit
DE102006033167A1 (de) * 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
WO2008042891A2 (en) * 2006-10-02 2008-04-10 Oregan Biomedical Engineering Institute, Inc. Chitosan ophthalmic devices and methods
WO2008157514A2 (en) * 2007-06-14 2008-12-24 Genesegues, Inc. Metal ion-treated biocompatible polymers useful for nanoparticles
DK2276505T3 (da) * 2008-03-20 2013-11-25 Krister Tano Næsespray eller næsedråber til behandling af forkølelse
JP4972714B2 (ja) * 2008-07-07 2012-07-11 トルテック コーポレーション 静電的に帯電した多作用鼻適用、製品および方法
WO2010134942A1 (en) * 2009-05-16 2010-11-25 Trutek Corp. Electrostatically charged multi-acting nasal application, product and method
JPWO2011142484A1 (ja) * 2010-05-14 2013-07-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
WO2013005446A1 (ja) * 2011-07-06 2013-01-10 株式会社Ｎｂｃメッシュテック 抗ウイルス性樹脂部材
GB2521488A (en) 2011-10-31 2015-06-24 Premiere Polish Company Ltd Personal care composition and a device for dispensing the same
WO2013168167A1 (en) 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
PL225045B1 (pl) * 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US20150018760A1 (en) * 2013-07-11 2015-01-15 Kathryn Morton HARDIN Nasal irrigation solution preparation system and method of preparation
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
JP6125660B2 (ja) * 2013-11-14 2017-05-10 日本曹達株式会社 抗パルボウイルス組成物
NO342617B1 (no) * 2014-06-18 2018-06-18 Meda Otc Ab Oral formulering omfattende et antibakterielt middel for å forebygge og/eller behandle halitose, dårlig ånde, munntørrhet eller sår hals
CA2959660A1 (en) 2014-09-03 2016-03-10 Genesegues, Inc. Therapeutic nanoparticles and related compositions, methods, and systems
AR100459A1 (es) * 2015-05-15 2016-10-05 Química Luar S R L Una composición farmacéutica antiviral de uso tópico
JP6570316B2 (ja) * 2015-05-25 2019-09-04 ロート製薬株式会社 爪用組成物
US10293012B2 (en) 2017-05-04 2019-05-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using extracts of melissa officinalis against filoviruses
WO2018208739A1 (en) * 2017-05-08 2018-11-15 Thomas Cahill Pharmaceutical compositions comprising caffeic acid chelates
MX2020014311A (es) 2018-06-25 2021-04-28 Triumph Pharmaceuticals Inc Metodos de inhibicion de infecciones microbianas utilizando composiciones que contienen zinc.
US11369578B2 (en) * 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
CN114732822B (zh) * 2019-03-13 2023-06-30 中国人民解放军军事科学院军事医学研究院 氨基葡萄糖及其衍生物作为抗病毒药物的应用
EP3888629A1 (de) * 2020-03-31 2021-10-06 Dr. Kurt Wolff GmbH & Co. KG Zusammensetzung zur behandlung oder vorbeugung einer virusinfektion
EP4135718A2 (de) * 2020-04-15 2023-02-22 SolyPlus GmbH Mittel und verfahren zur vorbeugung und behandlung von infektionen
WO2021209493A2 (en) * 2020-04-15 2021-10-21 Solyplus Gmbh Means and methods of preventing and treating infections
US12186335B2 (en) 2020-04-23 2025-01-07 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
KR102651711B1 (ko) * 2020-04-27 2024-03-27 조석형 항균 및 항바이러스제, 이의 제조방법 및 이로부터 제조된 보조사료
MX2023002109A (es) * 2020-08-24 2023-07-13 Nanomerics Ltd Inhibidores virales.
EP3973966B1 (de) * 2020-09-24 2025-02-26 Dr. Kurt Wolff GmbH & Co. KG Hydroxyapatitzusammensetzung zur behandlung und/oder vorbeugung einer virusinfektion
WO2022185326A1 (en) * 2021-03-03 2022-09-09 Amitava Mazumder Antiviral, anti sars-cov-2, anti h1n3, antibacterial and antimicrobial compositions and methods of preparation thereof
JP7627445B2 (ja) 2021-04-16 2025-02-06 株式会社日本触媒 抗コロナウイルス剤
PT117220B (pt) 2021-05-11 2024-07-16 Inst Superior Tecnico Solução desinfetante compreendendo álcool e quitosano, processo para a sua obtenção e respetivos usos
WO2024135675A1 (ja) * 2022-12-22 2024-06-27 サンスター株式会社 抗インフルエンザウイルス用咽喉用組成物、及び咽喉用抗インフルエンザウイルス剤

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404987A (en) * 1965-03-31 1968-10-08 Procter & Gamble Food preservative compositions and method for inhibiting microbial growth in food products
LU77562A1 (de) 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0012115A1 (de) 1978-12-04 1980-06-11 Ciba-Geigy Ag Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen
US4503070A (en) 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US4956385A (en) 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
AU553789B2 (en) 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
US4661354A (en) 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
EP0285357A3 (de) 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Bekämpfung von Retroviren
JP3095488B2 (ja) * 1991-10-30 2000-10-03 株式会社資生堂 噴霧用ゲル基剤およびそれを用いた噴霧用点鼻剤
GB9202464D0 (en) 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
EP0692253A4 (de) 1992-08-07 1998-06-03 Nippon Soda Co Prophylaktikum gegen mastitis bei haustieren
US6321750B1 (en) 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
FR2715300B1 (fr) 1994-01-24 1996-03-29 Aromafarm Ltd Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.
HRP950149A2 (en) 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
SE518597C2 (sv) 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
JP3837769B2 (ja) 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
GB9525083D0 (en) 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US6344210B2 (en) * 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
SE507028C2 (sv) 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US20020022660A1 (en) * 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
DE19818842C1 (de) 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
US6080783A (en) 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
WO2000015192A1 (en) 1998-09-17 2000-03-23 Zonagen, Inc. Methods and materials related to bioadhesive contraceptive gels
US6231889B1 (en) 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6428814B1 (en) 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6423329B1 (en) * 1999-02-12 2002-07-23 The Procter & Gamble Company Skin sanitizing compositions
US20020151521A1 (en) 1999-03-30 2002-10-17 Burke Peter A. Universal antiviral composition
US6570054B1 (en) 1999-05-21 2003-05-27 The Procter & Gamble Company Absorbent article having a stable skin care composition
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
FR2801601B1 (fr) * 1999-11-26 2003-04-25 Rhodia Chimie Sa Complexe silicone reticulable thermiquement / adhesif dont l'interface possede une force de decollement modulable
US20030206958A1 (en) 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
JP2001271098A (ja) * 2000-03-24 2001-10-02 Lion Corp 電解洗浄水及びその製造方法、並びに、その電解洗浄水を用いる衣類又は食器の洗浄システム
US6638915B1 (en) 2000-06-30 2003-10-28 Harold Killam Anti-viral composition
US20020136768A1 (en) 2000-11-14 2002-09-26 Staats Victor J. Antimicrobial composition
CA2680475A1 (en) * 2000-12-28 2002-07-11 Shigeyuki Takada Sustained-release preparation
CA2452725A1 (en) * 2001-07-02 2003-01-16 Surecide Technologies, Llc Novel synergistic antimicrobial compositions and methods
EP1456292A1 (de) 2001-12-21 2004-09-15 E.I. Du Pont De Nemours And Company Antimikrobielle feste oberflächenmaterialien, die chitosan-metall-komplexe enthalten
EP1480517A4 (de) 2002-02-07 2007-08-22 Univ Columbia Zinksalzzusammensetzungen für die vorbeugung von schleimhautreizung durch spermizide und mikrobizide
AU2003274800A1 (en) 2002-10-31 2004-05-25 Lae-Ok Park Anticancer or antiviral composition
WO2004080210A1 (en) 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea
CN1267102C (zh) 2003-06-05 2006-08-02 广西半宙制药股份有限公司 一种具有抗病毒作用的复合物及其制备方法

Also Published As

Publication number Publication date
DE602004018032D1 (de) 2009-01-08
WO2005074947A3 (en) 2005-09-22
US7968122B2 (en) 2011-06-28
JP2007513959A (ja) 2007-05-31
MXPA06006650A (es) 2007-01-26
BRPI0417559A (pt) 2007-03-27
US8470346B2 (en) 2013-06-25
NO20063147L (no) 2006-09-08
US20110223259A1 (en) 2011-09-15
KR20060118573A (ko) 2006-11-23
MA28334A1 (fr) 2006-12-01
EA200601124A1 (ru) 2006-12-29
AU2004315262A1 (en) 2005-08-18
IL176161A0 (en) 2006-10-05
DK1706122T3 (da) 2009-03-23
EP1706122A2 (de) 2006-10-04
CA2549083A1 (en) 2005-08-18
US20050232895A1 (en) 2005-10-20
WO2005074947A2 (en) 2005-08-18
EP1706122B1 (de) 2008-11-26

Similar Documents

Publication Publication Date Title
ATE415166T1 (de) Antivirale pharmazeutische zusammensetzungen
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20074807L (no) Fast farmasoytisk doseringsformulering
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
WO2007010034A3 (de) Ampholytisches copolymer, dessen herstellung und verwendung
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
NO20044898L (no) Nye etonogestrel estere
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
NL1021693A1 (nl) Deactiveerbare biociden voor koolwaterstofhoudende producten.
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
IT1318401B1 (it) Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono.
DK1713438T3 (da) Medicinsk sæbe
ITTO20010694A0 (it) Metodo di crittografia.
ITTO20020744A1 (it) Composizione.
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
DZ3441A1 (fr) Nouvelles phenylpiperazines.
ITMI20001696A0 (it) Derivati di carnosina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
BRPI0410638A (pt) derivados de azitromicina
WO2006009696A3 (en) Anticoagulant contrast media
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties